QTMeds

Drug Database Monograph

VFEND 200 mg

✓ VERIFIED BY DOCTOR

Active Ingredient: VORICONAZOLE

QTc Interval Status:
prolongation

Clinical Description (Database Summary)

(Hérité de VORICONAZOLE ACCORD 200 mg) (Hérité de VORICONAZOLE TEVA 200 mg)

Scientific Sources / References

https://doi.org/10.1007/s00228-017-2284-5, https://www.fda.gov/media/178811/download

← Back to Prescription Analyzer